Overall rank by patents
#13,285
Across all tracked assignees
USPTO PatentsView assignee record - 22 granted patents across 14 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F21V (FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR).
The verdict
Amerlux holds 22 US patents across 14 technology areas, rank #13,285 of 50,000 tracked assignees.
Amerlux, Llc has been granted 22 US utility patents between 2015 and 2025, placing Amerlux, Llc at rank #13,285 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.2 claims per patent with primary concentration in F21V (FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR). As a US Corporation, Amerlux, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Amerlux sits between Albany Molecular Research, Inc. (22 patents, rank #13,281) and Astec Co., Ltd. (22 patents, rank #13,289) - the closest US assignees by grant volume. The composite Innovation Score of 34.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 16 in the 2015–2019 window, a -62% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Amerlux, Llc's 13.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 14 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Amerlux, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ALBANY MOLECULAR RESEARCH, INC.
22 patents
ALCRESTA THERAPEUTICS, INC.
22 patents
ALCYONE LIFESCIENCES, INC.
22 patents
AMERICAN MAID PLASTIC CO.
22 patents
ANDES TECHNOLOGY CORPORATION
22 patents
ANGIOSCORE, INC.
22 patents
ASSOCIATION INSTITUT DE MYOLOGIE
22 patents
ASTEC CO., Ltd.
22 patents
AMERLUX, LLC
22 patents
What this shows Amerlux holds 22 patents at rank #13,285, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,285 in granted patent volume.
Other assignees with the most granted patents in Amerlux's primary technology class.
Amerlux's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 52% higher than 48% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 13.6% |
| 2016 | 2 | 9.1% |
| 2017 | 4 | 18.2% |
| 2018 | 5 | 22.7% |
| 2019 | 2 | 9.1% |
| 2020 | 2 | 9.1% |
| 2021 | 1 | 4.5% |
| 2022 | 1 | 4.5% |
| 2024 | 1 | 4.5% |
| 2025 | 1 | 4.5% |
Top 14 of 14 technology areas
Overall rank by patents
#13,285
Across all tracked assignees
34.7 out of 100
How to use this portfolio
Amerlux's 22 grants land it in the top 52% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.